Hematology Market is Anticipated to Witness High Growth Owing to Rising Prevalence of Blood Disorders
Hematology Market |
The hematology market is primarily involved in manufacturing equipment used for hematology analysis and diagnosis. Hematology analyzers help evaluate the quality and quantity of the three cellular components of blood namely red blood cells, white blood cells, and platelets. The devices provide critical information including complete blood count, platelet counts, hemoglobin levels, etc. which help diagnose conditions like anemia, leukemia, infections and other blood-related disorders. Growing prevalence of blood disorders owing to changing lifestyle practices and increasing geriatric population has significantly driven the demand for routine blood screening and analysis.
The global hematology market is estimated to be valued
at US$ 2.53 billion in 2024 and is expected to exhibit a CAGR of 6.9% over the
forecast period 2024 to 2030.
Key Takeaways
Key players operating in the hematology market are Shaanxi Undersun Biomedtech
Co., Ltd., Tocris Bioscience (Bio-Techne Corporation), BioOrigin, Nature's
Sunshine Products, Inc., Organic Herb Inc., Damin Foodstuff (Zhangzhou) Co.,
Ltd., Nutra Green Biotechnology Co., Ltd., Xian Yuensun Biological Technology
Co., Ltd., Guangxi Yiyuan Biotechnology Co., Ltd., Changsha Heking Bio-Tech
Co., Ltd., Hangzhou Botanical Technology Co., Ltd., Novoherb Technologies,
Jiangsu Changhai Food Additive Co., Ltd., Xian Sost Biological Science &
Technology Co., Ltd., Xi'an Plant Bio-Engineering Co., Ltd..
The rising prevalence of blood cancers like leukemia presents significant
opportunities for market players. According to statistics, nearly 400,000 new
cases of leukemia are reported annually worldwide representing huge market
potential. Companies are focusing on developing advanced diagnostic tools and
workflows for rapid and accurate leukemia detection and subtype classification
which is expected to drive the Hematology
Market Demand.
Key players are also exploring opportunities in developing markets through
partnerships, acquisitions and establishing manufacturing and distribution
facilities. For instance, Sysmex Corporation has expanded its operations across
Asia Pacific, Latin America and Africa through strategic collaborations to
cater to the growing testing needs of developing healthcare systems.
Market Drivers
Growing geriatric population: Risk of various blood disorders substantially
increases with age. As per estimations, over 16% of global population will be
aged 65 years and above by 2050 presenting a large patient base requiring
frequent blood testing. This demographic shift is a major market driver.
Technological advancements: Introduction of automation, digitalization,
artificial intelligence and other technologies have improved diagnostic
accuracy and efficiency of hematology analyzers. Integrated workflow solutions
combined with advanced visualization and data analytics are facilitating early
disease detection.
Market Restraints
High costs associated: Hematology analyzers have substantial price tags ranging
from $20,000 to $100,000 which is a major restraint, especially in low resource
settings. High maintenance and consumables costs further add to the economic
burden.
Lack of skilled professionals: Effective utilization of advanced hematology
equipment requires trained medical technologists and technicians. However,
shortage of trained manpower is seen across developing regions which negatively
impacts market growth.
Segment Analysis
The hematology market is dominated by hematology analyzers sub segment due to
growing demand for automated hematology analyzers. Hematology analyzers provide
accurate, fast and efficient blood analysis by automating the blood cell
counting process. Manual microscopic examination of blood samples is time
consuming and require skilled professionals. Whereas automated hematology
analyzers can accurately analyze over hundreds of blood samples in an hour by
precisely identifying and counting various blood cells such as white blood
cells, red blood cells and platelets. This has led to widespread adoption of
hematology analyzers by diagnostic laboratories and research institutes.
Global Analysis
North America dominates the hematology market owing to presence of leading
market players, advanced healthcare infrastructure and rising healthcare
spending. Growing prevalence of blood disorders and cancer in the US and Canada
is also augmenting market growth. Europe holds the second largest market share
on account of increasing research activities in hematology and rising
healthcare awareness. Meanwhile, Asia Pacific is estimated to be the fastest
growing market due to growing healthcare expenditure, improving medical
facilities and expanding patient pool in developing nations like China and
India. Growing geriatric population susceptible to blood disorders in Japan is
also fueling market growth in the region.
Get More Insights on this topic- https://www.newswirestats.com/hematology-market-growth-analysis/
Comments
Post a Comment